Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan
· Delayed Price · Currency is TWD 34.70
+0.55 (1.61%)
At close: Jun 10, 2025
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 5.39 billion as of June 17, 2025. Its market cap has decreased by -24.47% in one year.
Market Cap
5.39B
Enterprise Value
3.82B
Revenue
16.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.70
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 5.39B, a decrease of -2.61%. That is a compound annual growth rate of -0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 5.53B | -2.27% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 175.63B |
| Caliway Biopharmaceuticals | 155.88B |
| Bora Pharmaceuticals Co., LTD. | 81.93B |
| Lotus Pharmaceutical | 57.85B |
| Oneness Biotech | 36.16B |
| Polaris Group | 30.24B |
| Center Laboratories | 27.71B |
| Lumosa Therapeutics | 27.69B |